Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 21:30:00 17/05/2024 BST 		5-day change 1st Jan Change
5.08 USD +0.99% Intraday chart for Moleculin Biotech, Inc. +6.28% -60.55%
05-15 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI
05-13 Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024
cc4c829f5e29aa17c814dc.VcVW9NYfVknI-IJWKhqtV8GXQAgJqrzVpARhIvdfdj8.N-gJuZNQIhuEl_Iuf1HgPYXeK0Jl6Na7lDUbWqA5G15koAGrh1UJH7mU9Q~94982c6e3d07ce2a3448e1b6cab23d73
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. News Chart